Physician
Pediatrics in Brevard, P.A.
Pediatrics in Brevard, P.A. was paid $5.13M by Medicaid between Jan 2019 and Jun 2022, across 56 billing codes. Its largest line is 99213, doctor's office visit, returning patient (routine) — 35% of everything it billed.
33Billing provider infoPEDIATRICS IN BREVARD, P.A.
ROCKLEDGE, FL 32955
ROCKLEDGE, FL 32955
33aNPI1629069240assigned 11/02/2005
33bProvider typePediatrics Physician
28Total paid$5.13M
24GClaims161,007
24DCodes billed56
24AFirst – last monthJan 2019 – Jun 2022
Compared with peers
Next to other Pediatrics Physician providers in Florida
Rank by total paid#68 of 971
Median peer was paid$238K
This provider vs. median22×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2019 | 34,144 | $1.41M | |
| 2020 | 40,342 | $1.66M | |
| 2021 | 32,079 | $1.52M | |
| 2022 | 54,442 | $544K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 35% | 29,979 | 23,483 | $1.80M |
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 13,217 | 10,288 | $1.14M |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 11% | 8,003 | 5,617 | $558K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 11% | 7,651 | 5,135 | $555K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 6.9% | 4,403 | 3,286 | $352K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | 3.1% | 1,915 | 1,669 | $157K |
| 90723 | 2.6% | 3,125 | 2,038 | $133K | |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 1.3% | 14,276 | 10,515 | $67K |
| 90633 | 1.0% | 1,383 | 914 | $53K | |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 4,341 | 2,382 | $48K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 4,864 | 2,989 | $43K |
| 90686 | <1% | 2,993 | 2,689 | $34K |
44 more codes
| 90461 | <1% | 4,880 | $23K | |
| 90651 | <1% | 375 | $22K | |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 317 | $17K |
| 85018 | <1% | 2,852 | $15K | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 3,930 | $11K |
| 99000 | <1% | 4,803 | $11K | |
| 90648 | <1% | 4,318 | $10K | |
| 99188 | <1% | 1,940 | $8K | |
| 99215 | Doctor's office visit, returning patient (complex) | <1% | 52 | $8K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | <1% | 5,145 | $6K |
| 90734 | <1% | 263 | $6K | |
| 96127 | <1% | 2,384 | $6K | |
| 90700 | <1% | 88 | $6K | |
| 99177 | <1% | 6,127 | $6K | |
| 92551 | <1% | 2,814 | $5K | |
| 99203 | Doctor's office visit, new patient (routine) | <1% | 76 | $4K |
| 99051 | <1% | 1,411 | $4K | |
| 90670 | <1% | 5,044 | $4K | |
| 90696 | <1% | 173 | $3K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 348 | $3K |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 723 | $2K |
| 80061 | Lipid panel | <1% | 243 | $2K |
| 96161 | <1% | 1,422 | $2K | |
| 90707 | <1% | 1,036 | $1K | |
| 81002 | <1% | 521 | $1K | |
| 90620 | <1% | 46 | $1K | |
| 99173 | <1% | 1,064 | $940.84 | |
| J7611 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, concentrated form, 1 mg | <1% | 14 | $789.59 |
| 36416 | <1% | 7,283 | $701.41 | |
| 0071A | <1% | 22 | $684.80 | |
| 90680 | <1% | 2,429 | $523.70 | |
| 90647 | <1% | 278 | $397.22 | |
| 90716 | <1% | 1,074 | $337.69 | |
| 83655 | <1% | 827 | $323.93 | |
| 87086 | Culture, bacterial; quantitative colony count, urine | <1% | 14 | $66.24 |
| 69210 | <1% | 15 | $63.82 | |
| 90685 | <1% | 64 | $46.01 | |
| 90715 | <1% | 40 | $24.01 | |
| 90472 | Immunization administration, each additional vaccine (list separately) | <1% | 100 | $10.00 |
| 87070 | <1% | 162 | $6.89 | |
| 91307 | <1% | 71 | $0.26 | |
| 90681 | 0% | 31 | $0.00 | |
| D0191 | 0% | 24 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 14 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialLOISELLE, MELISSA (CREDENTIALING COORDINATOR)